pirenzepine has been researched along with Paranoia in 5 studies
Pirenzepine: An antimuscarinic agent that inhibits gastric secretion at lower doses than are required to affect gastrointestinal motility, salivary, central nervous system, cardiovascular, ocular, and urinary function. It promotes the healing of duodenal ulcers and due to its cytoprotective action is beneficial in the prevention of duodenal ulcer recurrence. It also potentiates the effect of other antiulcer agents such as CIMETIDINE and RANITIDINE. It is generally well tolerated by patients.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 4 (80.00) | 18.2507 |
2000's | 1 (20.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Debattista, C | 1 |
Solvason, HB | 1 |
Belanoff, J | 1 |
Schatzberg, AF | 1 |
al Jeshi, A | 1 |
Von Hayek, D | 1 |
Hüttl, V | 1 |
Reiss, J | 1 |
Schweiger, HD | 1 |
Füessl, HS | 1 |
Rudolf, J | 1 |
Ghaemi, M | 1 |
Schmülling, S | 1 |
Woolley, J | 1 |
Smith, S | 1 |
5 other studies available for pirenzepine and Paranoia
Article | Year |
---|---|
Treatment of psychotic depression.
Topics: Antipsychotic Agents; Benzodiazepines; Depressive Disorder; Humans; Male; Middle Aged; Olanzapine; P | 1997 |
Paranoia and agitation associated with olanzapine treatment.
Topics: Adult; Antipsychotic Agents; Benzodiazepines; Female; Humans; Male; Olanzapine; Paranoid Disorders; | 1998 |
[Hyperglycemia and ketoacidosis associated with olanzapine].
Topics: Adult; Antipsychotic Agents; Benzodiazepines; Diabetic Ketoacidosis; Fatal Outcome; Female; Humans; | 1999 |
Deterioration of parkinsonian symptoms following treatment of dopaminergic hallucinosis with olanzapine.
Topics: Aged; Antiparkinson Agents; Antipsychotic Agents; Basal Ganglia Diseases; Benzodiazepines; Clozapine | 1999 |
Lowered seizure threshold on olanzapine.
Topics: Adult; Antipsychotic Agents; Benzodiazepines; Humans; Male; Olanzapine; Paranoid Disorders; Pirenzep | 2001 |